Background The effect of early as compared with later initiation of direct oral anticoagulants (DOACs)
in persons with atrial fibrillation who have had an acute ischemic stroke is unclear. …

Objective We aimed to estimate the incidence of cerebral sinus and venous thrombosis (CVT)
within 1 month from first dose administration and the frequency of vaccine‐induced …

Background Haematoma expansion is a major cause of mortality in intracranial haemorrhage
related to vitamin K antagonists (VKA-ICH). Normalisation of the international normalised …

Importance Thrombosis with thrombocytopenia syndrome (TTS) has been reported after
vaccination with the SARS-CoV-2 vaccines ChAdOx1 nCov-19 (Oxford–AstraZeneca) and Ad26.…

Background and Purpose— Optimal timing of tracheostomy in ventilated patients with severe
stroke is unclear. We aimed to investigate feasibility, safety, and potential advantages of …

Background and Purpose— Herniation attributable to unilateral mass effect is the major cause
of death in cerebral venous thrombosis (CVT). Decompressive surgery may be lifesaving …

Background Patients with acute intracerebral hemorrhage who are receiving factor Xa inhibitors
have a risk of hematoma expansion. The effect of andexanet alfa, an agent that reverses …

Rationale Optimal secondary prevention of embolic stroke of undetermined source is not
established. The current standard in these patients is acetylsalicylic acid, despite high …

Importance Intracerebral hemorrhage (ICH) is the most devastating adverse event in patients
receiving oral anticoagulation. There is only sparse evidence regarding ICH related to the …

Background Intravenous thrombolysis with alteplase within a time window up to 4.5 h is the
only approved pharmacological treatment for acute ischemic stroke. We studied whether …